Why the study?
Many clinical decision support systems generate excessive, clinically irrelevant alerts, but substantial barriers arose when integrating a method to suppress false-positive alerts into commercial EHR systems.
Current commercial EHR systems lack the flexible CDS infrastructure required to implement novel methods for suppressing clinically irrelevant drug allergy alerts.
Answers are grounded in this paper and cite their sources.
Current EHRs block suppression of irrelevant alerts; leaves open the need for vendor-supported CDS flexibility.
Despite the proven usefulness of appropriate clinical decision support (CDS) alerts, many CDS systems fire excessive, clinically irrelevant alerts that are often ignored by clinicians. We have developed a method to suppress false-positive alerts based on prior drug tolerance but encountered substantial barriers to integrating the method into widely adopted commercial electronic health record (EHR) systems.This study aimed to describe the challenges faced while attempting to integrate our method into the CDS infrastructure of two commercial EHR systems and provide recommendations for future research and CDS design.Using a multifaceted approach, we investigated (1) the use of emergent CDS standards (e.g., CDS Hooks) to create a scalable solution to augment off-the-shelf EHR-based alerts with patient-specific custom alerts, (2) customize CDS rules of commercial medication knowledge bases (MKBs) to reduce false-positive alerts, and (3) manually inactivate allergy documentation in patients with prior drug tolerance.We were unable to implement the standards-based approach because support for CDS Hooks was found to be tailored to specific scenarios that involve the creation of new drug allergy alerts (DAAs) but not the suppression of vendor-supplied DAAs. Likewise, we were unable to suppress alerts imported from MKBs into the EHR systems investigated because these systems do not support discrete clinical documentation changes that drive DAAs. Lastly, we determined that although manually inactivating allergy documentation in patients with prior drug tolerance is possible, doing so requires the impractical solution of creating and maintaining individual rules for each drug at the ingredient level.We describe the barriers that precluded implementation of a novel method to suppress clinically irrelevant CDS alerts in two commercial EHR systems. Overcoming these barriers will require a more flexible CDS infrastructure, as well as collaboration and shared responsibility across diverse stakeholders.
No takes yet. Share an insight, caveat, or question.
Colicchio et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: